×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance
Here is how Aligos Therapeutics, Inc. (ALGS) and Allogene Therapeutics (ALLO) have performed compared to their sector so far this year.
4 months ago
Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
ABC4 Utah
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage...
1 week ago
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) Share Price Is Matching Sentiment Around Its Revenues
Simply Wall Street
It's clear to see that Aligos Therapeutics maintains its low P/S on the weakness of its forecast for sliding revenue, as expected. As other...
2 months ago
Aligos Therapeutics describes new prodrugs to treat hepatitis B and D virus infections
BioWorld MedTech
Aligos Therapeutics Inc. has identified prodrugs reported to be useful for the treatment of hepatitis B and hepatitis D viral infections.
2 weeks ago
Aligos Therapeutics on the Brink: The Urgent Race to Maintain Nasdaq Listing and Avoid Delisting Consequences ...
Tipranks
Aligos Therapeutics, Inc. (ALGS) has disclosed a new risk, in the Share Price & Shareholder Rights category. Aligos Therapeutics, Inc. faces...
1 month ago
Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024
MyChamplainValley.com
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage...
2 months ago
Vanguard Group Inc. Increases Stock Position in Aligos Therapeutics, Inc. (NASDAQ:ALGS)
Defense World
Read Vanguard Group Inc. Increases Stock Position in Aligos Therapeutics, Inc. (NASDAQ:ALGS) at Defense World.
3 weeks ago
Liver specialist Aligos scores $92m in private placement funding
Pharmaceutical Technology
As it builds momentum towards a Phase IIa study for its NASH drug, Aligos aims to be a THR-β agonist market contender.
6 months ago
Aligos Therapeutics, Inc. (ALGS) Just Flashed Golden Cross Signal: Do You Buy?
Yahoo Finance
After reaching an important support level, Aligos Therapeutics, Inc. (ALGS) could be a good stock pick from a technical perspective.
1 month ago
Aligos Therapeutics (ALGS) Scheduled to Post Earnings on Tuesday
MarketBeat
Aligos Therapeutics (NASDAQ:ALGS) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports.
5 days ago